Labeler · US market
Oryza Pharmaceuticals Inc.
Oryza Pharmaceuticals Inc. is a US drug labeler with US FDA registrations covering 7 drug concepts (7 currently active) across 36 packages.
ACTIVE - US
openFDA · updated weekly
Labeler codes72516
Active drugs7
Registrations21 active / 21
Packages36
Sole supplier of0 drugs
No company profile yet
FDA filings tell us what Oryza Pharmaceuticals Inc. registers, not who it is. If you know this company - what it makes, who owns it, where it manufactures - you can add it. Every submission is reviewed before it goes live.
Submit information about this company →Portfolio7 drugs · US
Every drug concept this labeler has US registrations for, by package count.
| Drug | Type | NDCs | Packages | Status |
|---|---|---|---|---|
| Metoprolol Succinate tablet, extended release | rx | 7 | 17 | SUPPLYING |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate tablet | rx | 6 | 6 | SUPPLYING |
| Bupropion Hydrochloride tablet, extended release |